1. Biobanks in the Era of Genomic Data
- Author
-
Juliann M. Savatt, W. Andrew Faucett, Yanfei Zhang, Ming Ta Michael Lee, Cassandra J. Pisieczko, and Janet L. Williams
- Subjects
0301 basic medicine ,Research program ,business.industry ,Best practice ,Corporate governance ,Internet privacy ,General Medicine ,030105 genetics & heredity ,Biobank ,Transparency (behavior) ,Data sharing ,03 medical and health sciences ,030104 developmental biology ,Confidentiality ,Return of results ,business - Abstract
Biobank research brings together participants, their samples and data, and researchers to provide a productive and efficient resource that advances discovery, prevention, diagnosis, and treatment. This mini-review addresses the importance of governance issues regarding consent, privacy and confidentiality, data sharing, and return of results in biobanks that utilize genomic sequencing data. With the availability of genomic sequencing data, there is renewed attention to the value of biobank research. Governance components of consent, data sharing, privacy protections, and disclosure of research results vary widely among biobanks currently established. There is no consensus standard of best practice for managing genomic data regardless of the biobank infrastructure. Understanding the various biobank research program components will aid genetics providers and other healthcare providers as they interact with biobank researchers and participants. Governance structures for biobanks will need to be informed by the engagement of participants, researchers, and regulatory agencies. Education concerning the importance of biobank research, transparency of governance structure, and the relationship of genomic data to the improvement of individual health is critical to support continued biobank research.
- Published
- 2019
- Full Text
- View/download PDF